Investigation of Mass Balance and Major Metabolites After Administration of 28 mg Radiolabeled ZK 219477 in Patients With Solid Tumor in an Open-label, Non Randomized Design
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Sagopilone (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Bayer
- 14 Feb 2008 The expected completion date for this trial is now 1 Nov 2007.
- 22 Jan 2008 Status changed from recruiting to completed.
- 14 Mar 2007 New trial record.